- Vivos Therapeutics (NASDAQ:VVOS) announces an offer to sell up to 854,332 shares by selling shareholders.
- The shares include 709,220 shares from the December 2024 private placement warrants, 95,467 shares from December 2024 and 49,645 shares from the September 2024 placement agent warrants.
- Vivos will not receive income from the resale of shares.
- VVOS shares rose nearly 3% in premarket trading on Wednesday.
- Source: SEC filing
Vivos Therapeutics Announces Sale of Up to 854,332 Shares by Selling Shareholders
